Amgen Exec: PBMs Factor Patient Cost Sharing Into Drug Net Prices

May 09, 2019
Pharmacy benefit managers often don't favor drugs with lower list prices, even when the discounted (net) price equals that of an identical drug with a higher list price, because patients pay more to insurers for the high-list-price drug, and that bigger patient cost sharing amount is factored into net prices used to gain placement on formularies, an Amgen executive told House Energy & Commerce health subcommittee members Thursday (May 9). Administrative fees that pharmacy benefit managers charge also are factored...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.